Witty worked to remake GSK’s image. Greater access to drugs became ... Since the assassination of his top lieutenant Brian ...
GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...
GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback